Taro Pharmaceutical Industries Ltd (FRA:TAL)
€ 39.6 0.2 (0.51%) Market Cap: 1.50 Bil Enterprise Value: 705.57 Mil PE Ratio: 29.67 PB Ratio: 0.90 GF Score: 76/100

Q2 2020 Taro Pharmaceutical Industries Ltd Earnings Call Transcript

Nov 05, 2019 / 01:00PM GMT
Release Date Price: €72
Operator

Good afternoon, ladies and gentlemen, and welcome to the Taro Pharmaceutical's Second Quarter 2019/2020 Earnings Call.

(Operator Instructions)

As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr. William Coote. Please go ahead, sir.

William J. Coote
Taro Pharmaceutical Industries Ltd. - Assistant VP of Business Finance & IR and Treasurer

Thank you. Good morning, everyone, and welcome to our fiscal 2019/2020 first half earnings call.

Joining me today on the call are Mr. Dilip Shanghvi, Chairman of the Board of Directors; Mr. Uday Baldota, Taro's CEO; and Mariano Balaguer, Vice President and CFO.

We hope you received a copy of the earnings press release, which can be found on our website at taro.com. We anticipate that many of you may have questions concerning not only this quarter's and year-to-date financial performance, but also our markets, operations, strategies and other matters. While we try to respond to most of your queries, we will not be able to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot